These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Improvement in correlation between oral dose of cyclosporine and cyclosporinemia after substitution of conventional cyclosporine by Neoral cyclosporine in 296 liver transplant patients. Bilbao I, Parrilla P, Rimola A, Figueras J, Fabrega E, Gomez M, De Vicente E, Margarit C. Transplant Proc; 1998 Aug; 30(5):1833-7. PubMed ID: 9723300 [No Abstract] [Full Text] [Related]
9. NOF-11: a one-year randomized double-blind comparison of Neoral versus Sandimmune in pediatric liver transplantation. Alvarez F, Atkison P, Grant D, Jones A, Kim P, Kneteman N, Laurin L, Martin S, Paradis K, Shapiro J, Smith L, Superina R, Tan A. Transplant Proc; 1998 Aug; 30(5):1961. PubMed ID: 9723352 [No Abstract] [Full Text] [Related]
11. Neoral as the initial immunosuppressant in liver transplantation; conversion from Sandimmune to Neoral in stable patients. Kizilisik AT, al-Sebayel M, Ramirez CB. Transplant Proc; 1998 Nov; 30(7):3537-8. PubMed ID: 9838549 [No Abstract] [Full Text] [Related]
12. Serum lipid changes in liver transplantation: effect of steroids withdrawn in a prospective randomized trial under cyclosporine A therapy. De Carlis L, Belli LS, Colella G, Rondinara GF, Slim AO, Alberti A, Aseni P, Sansalone CV, Pirotta V, Di Benedetto F, Forti D. Transplant Proc; 1999 Nov; 31(1-2):391-3. PubMed ID: 10083156 [No Abstract] [Full Text] [Related]
13. Successful reconversion from tacrolimus to cyclosporine A Neoral in pediatric liver recipients. Melter M, Rodeck B, Kardorff R, Hoyer PF, Maibücher A, Brodehl J. Transplant Proc; 1996 Aug; 28(4):2276-8. PubMed ID: 8769224 [No Abstract] [Full Text] [Related]
14. Safety of conversion from cyclosporine Sandimmune to cyclosporine Neoral in stable liver transplant patients. Baruch Y, Assy N, Kramsky R, Enat R. Transplant Proc; 1998 Aug; 30(5):1852-3. PubMed ID: 9723306 [No Abstract] [Full Text] [Related]
15. Increased dosage requirement and rejection after Neoral conversion in pediatric liver transplant patients. Cao S, Cox KL, Berquist W, So S, Concepcion W, Monge H, Esquivel CO. Transplant Proc; 1998 Dec; 30(8):4322-4. PubMed ID: 9865373 [No Abstract] [Full Text] [Related]
16. Conversion from the conventional cyclosporine formulation (Sandimmune) to a new oral microemulsion (Neoral) in stable liver transplant patients. Dibo-Cohen JM, Conort O, Conti F, Bernard D, Hazebroucq G, Calmus Y. Transplant Proc; 1998 Aug; 30(5):1857. PubMed ID: 9723309 [No Abstract] [Full Text] [Related]